Tech Company Financing Transactions
Human Longevity Funding Round
On 11/7/2019, Human Longevity raised $30 million in funding from Emerging Technology Partners and private investors.
Transaction Overview
Company Name
Announced On
11/7/2019
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
HLI will use the proceeds from this financing to enhance our Health Nucleus intelligence platform, which is using integrated metrics derived from specialized imaging, whole genome sequencing and other lab tests with machine learning and AI to create a comprehensive standard for measuring your health and performance.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4570 Executive Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Wei He
Chief Medical Officer
Thomas Caskey
Chief Technical Officer
Scott Sorensen
President
David Karow
VP - Bus. Development
Anita Cosgrove
VP - Bus. Development
Travis Lacey
VP - Bus. Development
Nan Zhou
VP - Engineering
Wayne Delport
VP - Engineering
Wei Zhou
VP - Marketing
Debbie Feinberg
VP - Operations
Scott Treml
VP - Product Management
Derek Zu
VP - Regulatory Affairs
Jennifer Dawson
Browse more venture capital transactions:
Prev: 11/7/2019: Wardrobe venture capital transaction
Next: 11/7/2019: FamePick venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs